Read More Pharma Industry News AbbVie reports 2024 financial results: Revenue growth driven by immunology and neuroscience AbbVie (NYSE: ABBV) has released its full-year and fourth-quarter 2024 financial results, showing continued revenue growth despite challenges… byPallavi MadhirajuFebruary 2, 2025